Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood flow clues may predict health of Growth-Restricted newborns

NCT ID NCT07193381

Knowledge-focused Sponsor: İlayda Gercik Arzık, MD Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study followed 81 pregnant women whose babies were growing slowly in the womb (a condition called IUGR). Researchers used ultrasound to measure blood flow in a key fetal blood vessel every week during the third trimester. They then checked if these measurements could predict which babies would have serious health problems after birth, such as needing intensive care or having low Apgar scores. The goal was to see if this simple test could help doctors identify high-risk babies earlier.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

81 people

The number who actually took part.

Started

Sep 2025

Finished

Mar 2026

Lead sponsor

A government agency

The lead sponsor is a government body.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Pregnant women aged 18-45 years with singleton pregnancies diagnosed with intrauterine growth restriction (IUGR) will be recruited from the Department of Perinatology at Izmir City Hospital. Eligible participants will be followed with serial Doppler ultrasound examinations of the ductus venosus during the third trimester and monitored until delivery and the early neonatal period.

Ages

18 to 45 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Female participants aged 18-45 years Singleton pregnancy Intrauterine growth restriction (IUGR) with estimated fetal weight \<10th percentile for gestational age Gestational age ≥24 weeks at enrollment Ability to comply with scheduled follow-up visits and Doppler examinations Signed informed consent obtained Exclusion Criteria: Multiple gestations (twins or higher-order pregnancies) Major fetal congenital anomalies Known chromosomal abnormalities Maternal chronic systemic diseases likely to affect fetal growth (e.g., uncontrolled diabetes mellitus, severe renal disease, severe hypertension) Maternal infections known to impact fetal growth (e.g., TORCH infections)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Intrauterine growth restriction (IUGR) are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

fetal growth restriction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Intrauterine growth restriction (IUGR)

Contacts and locations

Locations

  • Izmir City Hospital

    Izmir, Bayrakli, 35540, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.